1. FDA, US. The use of physiologically based pharmacokinetic analyses — biopharmaceutics applications for Oral drug product development, Manufacturing Changes, and Controls https://www.fda.gov/media/142500/download. 2020. Accessed July 1st, 2022.
2. FDA, US. Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs — General Considerations https://www.fda.gov/media/88254/download. 2014. Accessed 1 July 2022.
3. FDA, US. Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA Guidance for Industry https://www.fda.gov/media/87219/download. 2021. Accessed 1 July 2022.
4. FDA, US. Dissolution testing of immediate release solid Oral dosage forms. 1997.
5. Moore J. Mathematical comparison of dissolution profiles. Pharm Technol. 1996;20:64–75.